Adagene
$13.399876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$13.39
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.19 (+1.44%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Adagene and other stocks, options, and ETFs commission-free!
About ADAG
Adagene, Inc. engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody.
CEO
Pei Zhi Luo
Employees
—
Headquarters
Suzhou, Jiangsu
Founded
2011
Market Cap
463.88M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
23.31K
High Today
$13.80
Low Today
$13.26
Open Price
$13.46
Volume
19.52K
52 Week High
$31.83
52 Week Low
$13.05
ADAG Earnings
-$0.40
-$0.27
-$0.13
$0.00
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 17, Pre-Market